Cargando…
CAR Based Immunotherapy of Solid Tumours—A Clinically Based Review of Target Antigens
SIMPLE SUMMARY: Cancer accounts for an increasing number of deaths year on year. However, new immune-based therapies offer promise in the quest to address this unmet need. One approach entails the use of immune white blood cells (usually collected from the patient themselves) and introducing a genet...
Autores principales: | Maher, John, Davies, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953298/ https://www.ncbi.nlm.nih.gov/pubmed/36829563 http://dx.doi.org/10.3390/biology12020287 |
Ejemplares similares
-
CAR-Based Immunotherapy of Solid Tumours—A Survey of the Emerging Targets
por: Maher, John, et al.
Publicado: (2023) -
Recent Advances in CAR-Based Solid Tumor Immunotherapy
por: Shin, Min Hwa, et al.
Publicado: (2023) -
HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
por: von Witzleben, Adrian, et al.
Publicado: (2020) -
Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies
por: Mazza, Roberta, et al.
Publicado: (2021) -
Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward
por: Li, Jian, et al.
Publicado: (2018)